Oncoceutics
Total Raised
$250KInvestors Count
5Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Oncoceutics has raised $250K over 6 rounds.
Oncoceutics's latest funding round was a Acquired for on January 8, 2021.
Oncoceutics's latest post-money valuation is from January 2021.
Sign up for a free demo to see Oncoceutics's valuations in January 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/8/2021 | Acquired | 5 | ||||
5/3/2020 | Loan | |||||
1/10/2018 | Corporate Minority | |||||
10/6/2015 | Series A - II | |||||
9/23/2014 | Series A |
Date | 1/8/2021 | 5/3/2020 | 1/10/2018 | 10/6/2015 | 9/23/2014 |
|---|---|---|---|---|---|
Round | Acquired | Loan | Corporate Minority | Series A - II | Series A |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 5 |
Oncoceutics Deal Terms
1 Deal Term
Oncoceutics's deal structure is available for 1 funding round, including their Acquired from January 08, 2021.
Round | Acquired |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired |
Oncoceutics Investors
5 Investors
Oncoceutics has 5 investors. Chimerix invested in Oncoceutics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/8/2021 | 1/8/2021 | 1 Acquired | Corporation | North Carolina | ||
Government | DC | |||||
Corporation | Pennsylvania | |||||
Private Equity | New York | |||||
Non-Profit Foundation | New York |
First funding | 1/8/2021 | ||||
|---|---|---|---|---|---|
Last Funding | 1/8/2021 | ||||
Investor | |||||
Rounds | 1 Acquired | ||||
Board Seats | |||||
Type | Corporation | Government | Corporation | Private Equity | Non-Profit Foundation |
Location | North Carolina | DC | Pennsylvania | New York | New York |
Loading...